This study investigated the changes in serum C5a levels in AD patients with different severity and found that serum C5a level was augmented with the severity of AD, and its expression was positively correlated with serum pro-inflammatory factor levels, and negatively correlated with cognitive function. Here, C5AR1 is linked to Alzheimer disease.